GURE · Gulf Resources, Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Bromine production capacity | 31,506 | fiscal year 2025 filing | — |
| Bromine tonnes sold | 6,024 | fiscal year 2025 filing | — |
| Bromine utilization ratio | 19% | fiscal year 2025 filing | — |
| Crude Salt tonnes sold | 93,916 | fiscal year 2025 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GURE
this stock
Gulf Resources, Inc.
|
$5.37M | -20.0% | +231.8% | — | 0.5% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$65.68B | +13.0% | — | — | 0.2% |
|
DOW
Dow Inc.
|
$21.68B | +28.7% | -7.0% | — | 4.7% |
|
NPXYY
Nippon Sanso Holdings Corporation/ADR
|
$15.00B | +17.2% | — | — | 0.0% |
|
CE
Celanese Corp
|
$5.25B | +13.2% | -7.1% | — | 5.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 15, 2026
- This year
- 26
Gulf Resources received approval to resume production at Factories No. 2 and No. 10, expected to increase annual production capacity by more than 20%. Test and trial production is expected in the fourth quarter of 2026.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GURE | -10.8% | -10.0% | -43.7% | -3.3% | -20.0% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -9.4% | -9.1% | -51.4% | -3.8% | -32.4% |